z-logo
open-access-imgOpen Access
Path From Clinical Research to Implementation
Author(s) -
Eveline Wiegers,
Kars C.J. Compagne,
Paula M. Janssen,
Esmée Venema,
Jaap W. Deckers,
Wouter J. Schonewille,
Jan Albert Vos,
Geert J. Lycklama à Nijeholt,
Bob Roozenbeek,
Jasper M. Martens,
Jeannette Hofmeijer,
R. van Oostenbrugge,
Wim H. van Zwam,
Charles B.L.M. Majoie,
Aad van der Lugt,
Hester F. Lingsma,
Yvo B.W.E.M. Roos,
Diederik W.J. Dippel,
Jelis Boiten,
Josje Brouwer,
Sanne J. den Hartog,
Wouter H. Hinsenveld,
Ma Kappelhof,
RobertJan B. Goldhoorn,
Maxim J.H.L. Mulder,
Ivo G.H. Jansen,
Adriaan C.G.M. van Es,
Bart J. Emmer,
Jonathan M. Coutinho,
Marieke J.H. Wermer,
Marianne A.A. van Walderveen,
Julie Staals,
Sebastiaan F. de Bruijn,
Lukas C. van Dijk,
H. Bart van der Worp,
Rob H. Lo,
Ewoud J. van Dijk,
Hieronymus D. Boogaarts,
Joost de Vries,
Paul L.M. de Kort,
Julia van Tuijl,
Jo J.P. Peluso,
Puck Fransen,
Jan S.P. van den Berg,
Boudewijn A.A.M. van Hasselt,
Leo A.M. Aerden,
René J. Dallinga,
Maarten Uyttenboogaart,
Omid Eschgi,
Reinoud P.H. Bokkers,
Tobien H.C.M.L. Schreuder,
Roel J.J. Heijboer,
Koos Keizer,
Lonneke S.F. Yo,
Heleen M. den Hertog,
Emiel J.C. Sturm,
Paul J.A.M. Brouwers,
Marieke E.S. Sprengers,
Sjoerd F.M. Jenniskens,
René van den Berg,
Albert J. Yoo,
Ludo F.M. Beenen,
Alida A. Postma,
Stefan D. Roosendaal,
Bas F.W. van der Kallen,
Ido R. van den Wijngaard,
Joost Bot,
PieterJan van Doormaal,
Anton Meijer,
Elyas Ghariq,
Marc P. van Proosdij,
G. Menno Krietemeijer,
Jo P. Peluso,
Dick Gerrits,
Wouter Dinkelaar,
Auke P.A. Appelman,
Bas Hammer,
Sjoert Pegge,
Anouk van der Hoorn,
Saman Vinke,
H. Zwenneke Flach,
Naziha el Ghannouti,
Martin Sterrenberg,
Corina Puppels,
Wilma Pellikaan,
Rita Sprengers,
Marjan Elfrink,
Michelle Simons,
Marjolein Vossers,
Joke de Meris,
Tamara Vermeulen,
Annet Geerlings,
Gina van Vemde,
Tiny Simons,
Cathelijn van Rijswijk,
Gert Messchendorp,
Nynke Nicolaij,
Hester Bongenaar,
Karin Bodde,
Sandra Kleijn,
Jasmijn Lodico,
Hanneke Droste,
Maureen Wollaert,
Sabrina Verheesen,
D. Jeurrissen,
Erna Bos,
Yvonne Drabbe,
Michelle Sandiman,
Nicoline Aaldering,
Berber Zweedijk,
Mostafa Khalilzada,
Jocova Vervoort,
Eva Ponjee,
Sharon Romviel,
Karin Kanselaar,
Denn Barning,
Vicky Chalos,
Ralph R. Geuskens,
Tim van Straaten,
Saliha Ergezen,
Roger R.M. Harmsma,
Daan Muijres,
Anouk de Jong,
Olvert A. Berkhemer,
Anna M.M. Boers,
Jordi Huguet,
P.F.C. Groot,
Marieke A. Mens,
Katinka R. van Kranendonk,
Kilian M. Treurniet,
Ma L. Tolhuisen,
Heitor Alves,
Annick J. Weterings,
Eleonora L.F. Kirkels,
Eva J.H.F. Voogd,
Lieve M. Schupp,
Sabine L. Collette,
Adrien E.D. Groot,
Natalie E. LeCouffe,
Praneeta R. Konduri,
Haryadi Prasetya,
Nerea ArrarteTerreros,
Lucas A. Ramos
Publication year - 2020
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.119.026731
Subject(s) - medicine
Before 2015, endovascular treatment (EVT) for acute ischemic stroke was considered a promising treatment option. Based on limited evidence, it was performed in several dedicated stroke centers worldwide on selected patients. Since 2015, EVT for patients with intracranial large vessel occlusion has quickly been implemented as standard treatment in many countries worldwide, supported by the revised international guidelines based on solid evidence from multiple clinical trials. We describe the development in use of EVT in the Netherlands before, during, and after the pivotal EVT trials. We used data from all patients who were treated with EVT in the Netherlands from January 2002 until December 2018. We undertook a time-series analysis to examine trends in the use of EVT using Poisson regression analysis. Incidence rate ratios per year with 95% CIs were obtained to demonstrate the impact and implementation after the publication of the EVT trial results. We made regional observation plots, adjusted for stroke incidence, to assess the availability and use of the treatment in the country. In the buildup to the MR CLEAN (Multicenter Clinical Trial of Endovascular Treatment of Acute Ischemic Stroke in the Netherlands), a slow increase of EVT patients was observed, with 0.2% of all ischemic stroke patients receiving EVT. Before the trial results were formally announced, a statistically significant increase in EVT-treated patients per year was observed (incidence rate ratio, 1.72 [95% CI, 1.46–2.04]), and after the trial publication, an immediate steep increase was seen, followed by a more gradual increase (incidence rate ratio, 2.14 [95% CI, 1.77–2.59]). In 2018, the percentage of ischemic stroke patients receiving EVT increased to 5.8%. A well-developed infrastructure, a pragmatic approach toward the use of EVT in clinical practice, in combination with a strict adherence by the regulatory authorities to national evidence-based guidelines has led to successful implementation of EVT in the Netherlands. Ongoing efforts are directed at further increasing the proportion of stroke patients with EVT in all regions of the country.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom